Ajantha Solomon

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann et al. · The Lancet HIV · 2014 · 641 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

Julian Elliott, Fiona Wightman, Ajantha Solomon et al. · PLoS Pathogens · 2014 · 511 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo

Philip Ellery, Emma Tippett, Ya‐Lin Chiu et al. · The Journal of Immunology · 2007 · 336 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Immunologic and Virologic Status after 14 to 18 Years of Infection with an Attenuated Strain of HIV-1 — A Report from the Sydney Blood Bank Cohort

Jennifer C. Learmont, Andrew F. Geczy, John Mills et al. · New England Journal of Medicine · 1999 · 328 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

Julian Elliott, James McMahon, Christina C. Chang et al. · The Lancet HIV · 2015 · 247 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9